11 patents
Utility
Compositions and Methods Using Cannabinoids for Treating Stammering/stuttering and Symptoms of Tourette Syndrome
18 Aug 22
This invention relates to compositions and methods for treating stammering/stuttering and Tourette syndrome (TS) in humans, using a formulation comprising of a combination of a Cannabis compound, or compounds.
Ramachandra MUKUNDA, Jagadeesh Sridhara RAO, Amar R. MUKUNDA
Filed: 26 May 20
Utility
Method and Composition for Treating Seizure Disorders
4 Aug 22
A composition for treating seizure disorders such as epilepsy comprises (i) an anticonvulsant drug of the hydantoin family; (ii) phytocannabinoid cannabidiol (CBD); and (iii) a fat-soluble vitamin.
Ramachandra MUKUNDA, Ranga Chelva KRISHNA
Filed: 21 Apr 22
Utility
Method and composition for treating seizure disorders
7 Jun 22
A composition for treating seizure disorders such as epilepsy comprises (i) an anticonvulsant drug of the hydantoin family; (ii) phytocannabinoid cannabidiol (CBD); and (iii) a fat-soluble vitamin.
Ramachandra Mukunda, Ranga Chelva Krishna
Filed: 14 Jun 17
Utility
Method and Composition for Relieving Fatigue and Restoring Energy
18 Nov 21
Methods and compositions for relieving general and chronic fatigue, restoring energy, rejuvenating sore muscles, and relieving associated pain by administering a composition including caffeine, and a Cannabis component having one or more compounds.
Ramachandra MUKUNDA, Jagadeesh Sridhara RAO
Filed: 4 Oct 19
Utility
Cannabinoid composition and method for treating pain
2 Mar 21
A combination of THC, CBD and Cobalamin (in a ratio of about 63%, 27% and 10%, respectively) is used with a topical carrier such as Shea butter cream to relieve pain.
Ramachandra Mukunda, Ranga Chelva Krishna
Filed: 1 Oct 18
Utility
Method and Composition for Treating CNS Disorders
28 Jan 21
Compositions and methods for treating a range of Central Nervous System (CNS) disorders and diseases such as amyloidosis, protein folding diseases, tauopathy, and specifically Alzheimer's Disease and Parkinson's Disease, among others, in humans and in veterinary animals, by administering to a subject in need thereof a formulation comprising of melatonin, curcumin and cannabis, specifically THC alone or with CBD.
Ramachandra MUKUNDA, Jagadeesh S. RAO, Amar R. MUKUNDA
Filed: 29 Mar 19
Utility
Composition for Treating Seizure Disorders
9 Dec 20
The invention provides compositions and methods for treating seizure disorders such as epilepsy in humans and animals using, in a first embodiment, the combination of (i) an effective amount of a barbiturate drug, such as phenobarbital or primidone, which solely enhances GABAergic inhibition in a patient suffering a seizure disorder; and (ii) phytocannabinoid cannabidiol (CBD) in a dosage amount sufficient to overcome the hepatic metabolic effect stimulated by the barbiturate drug and provide bioavailable CBD to the patient in clinically efficacious amounts.
Ramachandra MUKUNDA, Ranga Chalva KRISHNA
Filed: 24 Aug 20
Utility
Composition and method for treating seizure disorders
24 Aug 20
The invention provides compositions and methods for treating seizure disorders such as epilepsy in humans and animals using, in a first embodiment, the combination of (i) an effective amount of a barbiturate drug, such as phenobarbital or primidone, which solely enhances GABAergic inhibition in a patient suffering a seizure disorder; and (ii) phytocannabinoid cannabidiol (CBD) in a dosage amount sufficient to overcome the hepatic metabolic effect stimulated by the barbiturate drug and provide bioavailable CBD to the patient in clinically efficacious amounts.
Ramachandra Mukunda, Ranga Chelva Krishna
Filed: 13 Jan 16
Utility
Method and Composition for Treating Seizure Disorders
10 Jun 20
A composition for treating seizure disorders such as epilepsy comprises (i) an anticonvulsant drug of the hydantoin family; (ii) phytocannabinoid cannabidiol (CBD); and (iii) a fat-soluble vitamin.
Ramachandra MUKUNDA, Ranga Chelva KRISHNA
Filed: 13 Jun 17
Utility
Method and composition for treating cachexia and eating disorders
23 Mar 20
The invention provides treating cachexia and eating disorders in humans and veterinary animals by administering a composition including: (i) cyproheptadine (CYP); and (ii) a cannabis compound selected from the group of cannabidiol (CBD) and mixtures of CBD and up to 50% tetrahydrocannabinol (THC).
Ramachandra Mukunda, Ranga Chelva Krishna
Filed: 10 Aug 16
Utility
Method and Composition for Treating Eating Disorders
12 Feb 20
Method and composition for treating eating disorders in humans and veterinary animals by administering a composition including: (i) mirtazapine, (ii) a cannabis compound and (iii) a fat-soluble vitamin.
Ramachandra MUKUNDA
Filed: 26 Feb 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first